- Home
- ICHR vs ABSI Comparison
ICHR vs ABSI Comparison
Compare ICHR & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICHR
- ABSI
- Stock Information
- Founded
- ICHR 1999
- ABSI 2011
- Country
- ICHR United States
- ABSI United States
- Employees
- ICHR N/A
- ABSI N/A
- Industry
- ICHR Semiconductors
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- ICHR Technology
- ABSI Health Care
- Exchange
- ICHR Nasdaq
- ABSI Nasdaq
- Market Cap
- ICHR 581.2M
- ABSI 505.4M
- IPO Year
- ICHR 2016
- ABSI 2021
- Fundamental
- Price
- ICHR $22.61
- ABSI $4.32
- Analyst Decision
- ICHR Strong Buy
- ABSI Strong Buy
- Analyst Count
- ICHR 6
- ABSI 6
- Target Price
- ICHR $29.80
- ABSI $7.98
- AVG Volume (30 Days)
- ICHR 884.7K
- ABSI 7.1M
- Earning Date
- ICHR 11-03-2025
- ABSI 11-11-2025
- Dividend Yield
- ICHR N/A
- ABSI N/A
- EPS Growth
- ICHR N/A
- ABSI N/A
- EPS
- ICHR N/A
- ABSI N/A
- Revenue
- ICHR $929,180,000.00
- ABSI $4,138,000.00
- Revenue This Year
- ICHR $14.64
- ABSI $40.12
- Revenue Next Year
- ICHR $5.82
- ABSI $331.37
- P/E Ratio
- ICHR N/A
- ABSI N/A
- Revenue Growth
- ICHR 15.45
- ABSI 27.32
- 52 Week Low
- ICHR $13.12
- ABSI $2.01
- 52 Week High
- ICHR $36.48
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- ICHR 60.47
- ABSI 58.62
- Support Level
- ICHR $20.59
- ABSI $4.14
- Resistance Level
- ICHR $23.17
- ABSI $4.99
- Average True Range (ATR)
- ICHR 1.34
- ABSI 0.41
- MACD
- ICHR 0.11
- ABSI -0.01
- Stochastic Oscillator
- ICHR 76.84
- ABSI 47.24
About ICHR Ichor Holdings
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.